HMPO-DAPy is an experimental antiviral drug.[1]
Names | |
---|---|
Preferred IUPAC name
[({(2R)-1-[(2,6-Diaminopyrimidin-4-yl)oxy]-3-hydroxypropan-2-yl}oxy)methyl]phosphonic acid | |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider | |
PubChem CID
|
|
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C8H15N4O6P | |
Molar mass | 294.204 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
References
edit- ^ Gammon, Don B.; Snoeck, Robert; et al. (December 2008). "Mechanism of Antiviral Drug Resistance of Vaccinia Virus: Identification of Residues in the Viral DNA Polymerase Conferring Differential Resistance to Antipoxvirus Drugs". Journal of Virology. 82 (24): 12520–12534. doi:10.1128/JVI.01528-08. PMC 2593306. PMID 18842735.
External links
edit